These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36299925)

  • 1. Association of Hepatic Steatosis With Coronary Artery Disease by Studying the Role of Individual and Demographic Risk Factors.
    Alserihy O; Alsallumi Y; Alzahrani F; Al-Sulami AS
    Cureus; 2022 Sep; 14(9):e29444. PubMed ID: 36299925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between Coronary Artery Disease and Non-Alcoholic Fatty Liver Disease Using Computed Tomography Coronary Calcium Scans.
    Cucoranu DC; Pop M; Niculescu R; Kosovski IB; Toganel RO; Licu RA; Bacârea A
    Curr Health Sci J; 2023; 49(2):244-250. PubMed ID: 37779834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary artery disease and non-alcoholic fatty liver disease: Clinical correlation using computed tomography coronary calcium scans.
    Kirby RS; Halegoua-DeMarzio D
    JGH Open; 2021 Mar; 5(3):390-395. PubMed ID: 33732887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental prognostic value of non-alcoholic fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease.
    Ichikawa K; Miyoshi T; Osawa K; Miki T; Toda H; Ejiri K; Yoshida M; Nakamura K; Morita H; Ito H
    Eur J Prev Cardiol; 2022 Feb; 28(18):2059-2066. PubMed ID: 34279027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of coronary artery calcification with hepatic steatosis in asymptomatic individuals.
    Chhabra R; O'Keefe JH; Patil H; O'Keefe E; Thompson RC; Ansari S; Kennedy KF; Lee LW; Helzberg JH
    Mayo Clin Proc; 2013 Nov; 88(11):1259-65. PubMed ID: 24138963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study 2：.
    Idilman IS; Akata D; Hazirolan T; Doganay Erdogan B; Aytemir K; Karcaaltincaba M
    J Diabetes; 2015 Mar; 7(2):279-86. PubMed ID: 24893617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Biomarkers are Associated With Atherosclerotic Cardiovascular Disease Among Patients With Nonalcoholic Fatty Liver Disease Undergoing Elective Angiography.
    Younossi ZM; Felix S; Jeffers T; Younossi E; Lam B; Nader F; Tran HA; Schneider I; Stepanova M
    Clin Gastroenterol Hepatol; 2022 May; 20(5):e1149-e1156. PubMed ID: 34464720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease.
    Braza-Boïls A; Marí-Alexandre J; Molina P; Arnau MA; Barceló-Molina M; Domingo D; Girbes J; Giner J; Martínez-Dolz L; Zorio E
    Liver Int; 2016 Aug; 36(8):1221-9. PubMed ID: 26901384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary Artery Disease is More Severe in Patients with Non-Alcoholic Steatohepatitis than Fatty Liver.
    Niikura T; Imajo K; Ozaki A; Kobayashi T; Iwaki M; Honda Y; Kessoku T; Ogawa Y; Yoneda M; Kirikoshi H; Saito S; Nakajima A
    Diagnostics (Basel); 2020 Feb; 10(3):. PubMed ID: 32111021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of non-alcoholic fatty liver disease in patients with coronary artery disease.
    Baharvand-Ahmadi B; Sharifi K; Namdari M
    ARYA Atheroscler; 2016 Jul; 12(4):201-205. PubMed ID: 28149317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.
    Duseja A; Singh SP; Saraswat VA; Acharya SK; Chawla YK; Chowdhury S; Dhiman RK; Jayakumar RV; Madan K; Misra SP; Mishra H; Modi SK; Muruganathan A; Saboo B; Sahay R; Upadhyay R
    J Clin Exp Hepatol; 2015 Mar; 5(1):51-68. PubMed ID: 25941433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome, hepatic steatosis, and cardiovascular risk in children.
    Rutigliano I; Vinci R; De Filippo G; Mancini M; Stoppino L; d'Apolito M; Giardino I; Macarini L; Pettoello Mantovani M; Campanozzi A
    Nutrition; 2017 Apr; 36():1-7. PubMed ID: 28336101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary CT Angiography in Asymptomatic Adults with Hepatic Steatosis.
    Yu MM; Tang XL; Jin H; Yang S; Yun H; Wang QB; Zeng MS
    Radiology; 2021 Dec; 301(3):593-601. PubMed ID: 34546127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of Liver Fat by MRI-PDFF Imaging in Patients with Suspected Non-alcoholic Fatty Liver Disease and Its Correlation with Metabolic Syndrome, Liver Function Test and Ultrasonography.
    Rodge GA; Goenka MK; Goenka U; Afzalpurkar S; Shah BB
    J Clin Exp Hepatol; 2021; 11(5):586-591. PubMed ID: 34511820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients.
    Zimmermann E; Anty R; Tordjman J; Verrijken A; Gual P; Tran A; Iannelli A; Gugenheim J; Bedossa P; Francque S; Le Marchand-Brustel Y; Clement K; Van Gaal L; Sørensen TIA; Jess T
    J Hepatol; 2011 Sep; 55(3):660-665. PubMed ID: 21238518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.
    Garteiser P; Castera L; Coupaye M; Doblas S; Calabrese D; Dioguardi Burgio M; Ledoux S; Bedossa P; Esposito-Farèse M; Msika S; Van Beers BE; Jouët P
    JHEP Rep; 2021 Dec; 3(6):100381. PubMed ID: 34786549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The associations between coronary artery disease, and non-alcoholic fatty liver disease by computed tomography.
    Saraya S; Saraya M; Mahmoud M; Galal M; Soliman HH; Raafat M
    Egypt Heart J; 2021 Oct; 73(1):96. PubMed ID: 34718898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation.
    Kim J; Lee DY; Park SE; Park CY; Lee WY; Oh KW; Park SW; Rhee EJ
    PLoS One; 2017; 12(7):e0180118. PubMed ID: 28686633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of nonalcoholic fatty liver disease (NAFLD) in patients of cardiovascular diseases and its association with hs-CRP and TNF-α.
    Ajmal MR; Yaccha M; Malik MA; Rabbani MU; Ahmad I; Isalm N; Abdali N
    Indian Heart J; 2014; 66(6):574-9. PubMed ID: 25634387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease.
    Puchakayala BK; Verma S; Kanwar P; Hart J; Sanivarapu RR; Mohanty SR
    World J Hepatol; 2015 Nov; 7(25):2610-8. PubMed ID: 26557954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.